AJP - Renal AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 297: F612-F619, 2009. First published July 8, 2009; doi:10.1152/ajprenal.00139.2009
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/F612    most recent
00139.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bibert, S.
Right arrow Articles by Bonny, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bibert, S.
Right arrow Articles by Bonny, O.

Mouse GLUT9: evidences for a urate uniporter

Stéphanie Bibert,1 Solange Kharoubi Hess,1 Dmitri Firsov,1 Bernard Thorens,2 Käthi Geering,1 Jean-Daniel Horisberger,1,{dagger} and Olivier Bonny1

Departments of 1Pharmacology and Toxicology and 2Physiology and Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland

Submitted 8 March 2009 ; accepted in final form 3 July 2009

GLUT9 (SLC2A9) is a newly described urate transporter whose function, characteristics, and localization have just started to be elucidated. Some transport properties of human GLUT9 have been studied in the Xenopus laevis oocyte expression system, but the type of transport (uniport, coupled transport system, stoichiometry ... .) is still largely unknown. We used the same experimental system to characterize in more detail the transport properties of mouse GLUT9, its sensitivity to several uricosuric drugs, and the specificities of two splice variants, mGLUT9a and mGLUT9b. [14C]urate uptake measurements show that both splice variants are high-capacity urate transporters and have a Km of ~650 µM. The well-known uricosuric agents benzbromarone (500 µM) and losartan (1 mM) inhibit GLUT9-mediated urate uptake by 90 and 50%, respectively. Surprisingly, phloretin, a glucose-transporter blocker, inhibits [14C]urate uptake by ~50% at 1 mM. Electrophysiological measurements suggest that urate transport by mouse GLUT9 is electrogenic and voltage dependent, but independent of the Na+ and Cl transmembrane gradients. Taken together, our results suggest that GLUT9 works as a urate (anion) uniporter. Finally, we show by RT-PCR performed on RNA from mouse kidney microdissected tubules that GLUT9a is expressed at low levels in proximal tubules, while GLUT9b is specifically expressed in distal convoluted and connecting tubules. Expression of mouse GLUT9 in the kidney differs from that of human GLUT9, which could account for species differences in urate handling.

uric acid; SLC2A9; splice variants



Address for reprint requests and other correspondence: O. Bonny, Dept. of Pharmacology and Toxicology, Univ. of Lausanne, Rue du Bugnon 27, CH-1005 Lausanne, Switzerland (e-mail: Olivier.Bonny{at}unil.ch)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.